Hexima

Hexima Limited is a biotechnology company actively engaged in the research and development of plant-derived molecules for use in human health and agriculture.

Learn more

Investor

For information relating to investor updates, financial information, share trading and presentations click the link below.

Investor News

Science

Hexima is developing technology for use in transgenic plants to prevent damage by fungal pathogens and insect pests and for the treatment of fungal infections and non-melanoma skin cancer in humans.

Learn more

April 2015 Shareholder Update

As you are aware, the company has been actively pursuing four programs to develop intellectual property that may provide value to shareholders. I outline the status of these programs in the attached April 2015 Shareholder Update. View HXL Shareholder...

Dr van der Weerden Appointed to Board of Directors

On behalf of my fellow Directors I am pleased to announce that Dr. Nicole van der Weerden has been appointed to the Hexima Limited Board of Directors, effective 16th December 2014. Dr. van der Weerden will become an Executive Director in addition to her current role...

Hexima Board Update

Please be advised that Hexima announced a number of changes to the Company’s Board at the 2014 Annual General Meeting, held 18th November 2014. View Hexima Board...

Resignation of Ross Dobinson and New Appointments

Shareholders are advised that the Board of Hexima Limited has accepted the resignation of Ross Dobinson as Executive Chairman and a director of the Company pursuant to his engagement arrangements, with effect on 17 November 2014. Mr. Dobinson will not perform any...

External Links

Take a look at these useful links to learn more about our industry.

Australian Academy of Science
Australian Science Media Centre logo